| Part of plant | Fraction or isolated compounds | Model | Disease model | Tissue | Effect | Dose | Refs. |
| Whole plant | Berberine | In vivo | Nonobese diabetic (NOD) mice | Spleen, liver, or kidney | ↓ Th1/Th2 cytokines | 50, 150, 500 mg | [52] | Whole plant | Berberine | In vitro | Normal | Human lung epithelial cells and fibroblasts | ↓ Inflammatory cytokine | 5 μM | [47] | Whole plant | Berberine | In vitro | Normal | Primary splenocytes in mice | ↓ TNF-α, IL-2, IL-4, IL-10 | 0.8, 1.6, 3.3 μM | [46] | Root | Berberine | In vitro | Arthritis and Candida albicans infection | Spleen | ↑ Joint inflammation, C. albicans infection not affected | 5, 10 mg | [41] | Root | Berberine | In vivo | Normal | NM | Antinociceptive and anti-inflammatory | 20, 40, 80, 160 mg/kg | [53] | Whole plant | Berberine | In vivo, in vitro | Normal | Splenic macrophages and dendritic cell | ↓ IL-4, ↑ IL-12, ↑ IFN-γ | 100 μg | [54] | Fruit | Berberine | In vivo | Acute and chronic inflammation in male rat | Groin border of rats | ↑ Light absorption of peritoneal fluid, ↓ chronic inflammation, ↓ chronic pain | 75, 150, 300 mg/kg | [55] | Root | Berberine, oxyacanthine | In vivo and in vitro | Paw edema in mice | Splenocytes | ↓ Delayed type hypersensitivity | 20, 100, 200 | [28] | Fruit | Berberine | In vitro | Normal | Human peripheral lymphocytes | ↓ CD69 | 25, 50, 100 μmol/L | [56] | NM | Berberine | In vivo, in vitro | Normal | Splenic dendritic cell | ↑ Apoptosis in DC | 1, 50 mg/kg | [51] | Root | Berberine | In vitro | Immunodeficiency | Splenic dendritic cell and splenocytes | ↑ IL-12, ↑ IFN-γ, ↑ CD11c | 100 μg/mL | [57] | NM | Berbamine | In vivo, in vitro | Autoimmune encephalomyelitis | Splenocyte | ↓ IFN-γ | 50 mg/kg | [58] | NM | Berberine | In vivo | Autoimmune encephalomyelitis | Spinal cord | ↓ Th17, ↓ NF-κB | 200 mg/kg | [59] | NM | Berberine | In vivo | Autoimmune neuritis | Lymph node mononuclear cells | ↓ TNF-α, ↓ IL-10 | 20 and 130 mg/kg | [60] | NM | Berberine | In vivo | Type 1 diabetic mice | Splenocyte | ↓ STAT1, ↓ STAT4, ↓ Th17 | 200 mg/kg | [42] | NM | Berberine | In vivo | Normal | Splenocyte | ↑ IL-12p40 | 1 μg/mL | [61] | NM | Berberine | In vivo | Autoimmune tubulointerstitial nephritis | Kidney | ↓ CD3+, ↓ CD4+, ↓ CD8+, ↓ TIN | 10 mg/kg | [48] | NM | Berberine | In vivo | Dextran sulfate sodium- (DSS-) induced intestinal injury and colitis in mice | Colon | ↓ TNF, ↓ IFN-γ, ↓ KC, ↓ IL-17 | 100 mg/kg | [49] | NM | Berberine | In vivo | Autoimmune encephalomyelitis | Brain | ↓ TUNEL-positive neuronal cells, ↓ gelatinase activity, ↓ laminin degradation | 30 mg/kg | [50] | Root | Berberine | In vivo | Toxoplasma gondii infection | Peritoneal fluid | Treatment of parasitic infection such as acute toxoplasmosis | 1, 2 g/kg | [62] | Fruit | Berberine | In vitro | Bacterial vaginosis | Vagina | Treatment of bacterial vaginosis | 0.75%, 2%, 5% | [63] |
|
|